TLVAX
Price
$21.59
Change
+$0.18 (+0.84%)
Updated
Apr 23 closing price
Net Assets
305.96M
VIEIX
Price
$125.59
Change
+$2.28 (+1.85%)
Updated
Apr 23 closing price
Net Assets
101.44B
Ad is loading...

TLVAX vs VIEIX

Header iconTLVAX vs VIEIX Comparison
Open Charts TLVAX vs VIEIXBanner chart's image
Timothy Plan Large/Mid Cap Value A
Price$21.59
Change+$0.18 (+0.84%)
VolumeN/A
Net Assets305.96M
Vanguard Extended Market Index Instl
Price$125.59
Change+$2.28 (+1.85%)
VolumeN/A
Net Assets101.44B
TLVAX vs VIEIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TLVAX vs. VIEIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLVAX is a Buy and VIEIX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIEIX has more cash in the bank: 101B vs. TLVAX (306M). VIEIX pays higher dividends than TLVAX: VIEIX (1.30) vs TLVAX (0.45). TLVAX was incepted earlier than VIEIX: TLVAX (26 years) vs VIEIX (28 years). TLVAX (1.49) is less costly to investors than VIEIX (0.05). TLVAX is a more actively managed with annual turnover of: 34.00 vs. VIEIX (11.00). TLVAX has a lower initial minimum investment than VIEIX: TLVAX (1000) vs VIEIX (5000000). VIEIX annual gain was more profitable for investors over the last year : -2.00 vs. TLVAX (-8.49). VIEIX return over 5 years is better than : 66.50 vs. TLVAX (47.32).
TLVAXVIEIXTLVAX / VIEIX
Total Expense Ratio1.290.052,580%
Annual Report Gross Expense Ratio1.490.052,980%
Fund Existence26 years28 years-
Gain YTD-5.140-14.33736%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets306M101B0%
Annual Yield % from dividends0.451.3035%
Returns for 1 year-8.49-2.00424%
Returns for 3 years-0.196.62-3%
Returns for 5 years47.3266.5071%
Returns for 10 years12.6880.2016%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRS1.190.09
+8.18%
Aclaris Therapeutics
APGE36.541.04
+2.93%
Apogee Therapeutics
RSI11.750.16
+1.38%
Rush Street Interactive
HBANP17.340.19
+1.11%
Huntington Bancshares
HLI155.510.53
+0.34%
Houlihan Lokey